Panel members are distinguished members of the scientific, research, and public communities appointed by the President of the United States to serve three-year terms.
John P. Williams, M.D., F.A.C.S.PCP Chair
Dr. Williams is a breast cancer surgeon and patient education advocate. He founded and is medical director of the Breast Cancer School for Patients, an online video-based cancer education platform. His policy interests focus on improving cancer outcomes and disparities by promoting a transparent and patient-focused national healthcare system.
He received an undergraduate degree in psychology with distinction from Duke University and his medical degree from UNC School of Medicine. Dr. Williams then completed his surgery residency at Baylor College of Medicine with Dr. Michael E. DeBakey. He is a clinical faculty member at the Institute for Biohealth Innovation at George Mason University and founded the Novant-UVA Breast Center in 2009. Dr. Williams practices breast surgery in Northern Virginia.
Edith Peterson Mitchell, MD, MACP, FCPP, FRCP (London)PCP Member
Dr. Mitchell is Clinical Professor of Medicine and Medical Oncology in the Department of Medical Oncology, Director of the Center to Eliminate Health Disparities, and Associate Director of Diversity Affairs at the Sidney Kimmel Cancer Center at Thomas Jefferson University. Dr. Mitchell is a retired Brigadier General, the first female physician to attain this rank in the history of the U.S. Air Force. Dr. Mitchell was the 116th President of the National Medical Association. Her research focuses on breast, colorectal, and pancreatic cancers and other GI malignancies involving new drug evaluation and chemotherapy, development of new therapeutic regimens, chemo-radiation strategies for combined modality therapy, patient selection criteria, supportive care, and disparities in cancer. She is a Principal Investigator for a NCI Lead Academic Participating Site grant and received the 2018 Jefferson Health Achievement Award in Medicine. Dr. Mitchell currently serves on the NIH Council of Councils and previously served on the NCI Clinical Trials and Translational Research Advisory Committee (CTAC) and the NCI Blue Ribbon Panel.
Robert A. IngramPCP Member
Mr. Ingram is a General Partner at Hatteras Venture Partners, a venture capital firm that invests in early stage life science companies. Prior to joining Hatteras, Mr. Ingram was Chief Executive Officer and Chairman of Glaxo/Wellcome. Mr. Ingram co-led the merger and integration that formed GlaxoSmithKline. In 2013, Bob received the NACD B. Kenneth West Lifetime Achievement Award from the National Association of Corporate Directors.
At the request of US President George H.W. Bush, Bob formed and chaired the CEO Roundtable on Cancer. In 2006, he was appointed by President George W. Bush to the National Institutes of Health, National Cancer Advisory Board. In 2014 he received the North Carolina Award for public service, the highest civilian honor the state can bestow on an individual. Bob currently serves on the board of the Research Triangle Foundation of North Carolina, the Research Triangle Institute, and is Chairman of the GlaxoSmithKline Foundation, and member of the Advisory Council of the Congressional Task Force on Biomedical Research and Innovation.
Mr. Ingram is a graduate of Eastern Illinois University.